Open Access
Issue
Med Sci (Paris)
Volume 40, Number 1, Janvier 2024
La cavité orale et les dents au cœur de la santé
Page(s) 49 - 56
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2023195
Published online 01 February 2024
  1. Suárez LJ, Garzón H, Arboleda S et al. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review. Front Immunol 2020; 11 : 591255. [CrossRef] [PubMed] [Google Scholar]
  2. Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: A comprehensive update. J Intern Med 2015 ; 278 : 369–395. [CrossRef] [PubMed] [Google Scholar]
  3. Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020; 18 : 521–38. [CrossRef] [PubMed] [Google Scholar]
  4. Claessens YE, Mouthon L. Maladies rares en médecine d’urgence: définition et classification des maladies auto-immunes. Références en médecine d’urgence. Collection de la SFMU 2013, Chap 1 : 1–12. [Google Scholar]
  5. Saccucci M, Di Carlo G, Bossù Met al. Autoimmune diseases and their manifestations on oral cavity : Diagnosis and clinical management. J Immunol Res 2018 ; 2018 : 6061825. [CrossRef] [Google Scholar]
  6. Vaillant L, Chauchaix-Barthès S, Hüttenberger B, et al. Le syndrome « gingivite érosive chronique » : Étude rétrospective de 33 cas. Annales de dermatologie et de vénéréologie 2000; 127 : 381–7. [Google Scholar]
  7. Bach JF. Revisiting the Hygiene Hypothesis in the Context of Autoimmunity. Front Immunol 2021; 11 : 615192. [CrossRef] [PubMed] [Google Scholar]
  8. De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol 2019 ; 195 : 74–85. [Google Scholar]
  9. Harrington LE, Hatton RD, Mangan PRet al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 ; 6 : 1123–1132. [CrossRef] [PubMed] [Google Scholar]
  10. Ortiz Wilczyñski JM, Olexen CM, Errasti AE, et al. GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection. PLoS Pathog 2020; 16 : e1009176. [CrossRef] [PubMed] [Google Scholar]
  11. Dutzan N, Kajikawa T, Abusleme L, et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med 2018; 10 : eaat0797. [CrossRef] [PubMed] [Google Scholar]
  12. Yokota SI, Hirata D, Minota Set al. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 2000 ; 5 : 337–346. [CrossRef] [PubMed] [Google Scholar]
  13. Miller WB. The Eukaryotic Microbiome: Origins and Implications for Fetal and Neonatal Life. Front Pediat 2016 ; 4 : 96. [CrossRef] [Google Scholar]
  14. Kobayashi R, Ogawa Y, Hashizume-Takizawa T, et al. Oral bacteria affect the gut microbiome and intestinal immunity. Pathog Dis 2020; 78 : ftaa024. [CrossRef] [PubMed] [Google Scholar]
  15. Atarashi K, Suda W, Luo C, Kawaguchi T, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 2017 ; 358 : 359–365. [CrossRef] [PubMed] [Google Scholar]
  16. Giordano-Kelhoffer B, Lorca C, March Llanes J, et al. Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review. Biomedicines 2022; 10 : 1803. [CrossRef] [PubMed] [Google Scholar]
  17. Siddiqui H, Chen T, Aliko Aet al. Microbiological and bioinformatics analysis of primary Sjogren’s syndrome patients with normal salivation. J Oral Microbiol 2016 ; 8 : 31119. [CrossRef] [PubMed] [Google Scholar]
  18. Otsuka K, Sato M, Tsunematsu T, et al. Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome. Viruses 2022; 14 : 1474. [CrossRef] [PubMed] [Google Scholar]
  19. Masuko K. Will the COVID-19 pandemic trigger future occurrence of autoimmunity like Sjögren’s syndrome?. Int J Rheum Dis 2021; 24 : 963–5. [CrossRef] [PubMed] [Google Scholar]
  20. Krutyholowa A, Strzelec K, Dziedzic A, et al. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol 2022; 13 : 980805. [CrossRef] [PubMed] [Google Scholar]
  21. Laugisch O, Wong A, Sroka Aet al. Citrullination in the periodontium—A possible link between periodontitis and rheumatoid arthritis. Clin Oral invest 2016 ; 20 : 675–683. [CrossRef] [PubMed] [Google Scholar]
  22. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021; 21 : 426–40. [CrossRef] [PubMed] [Google Scholar]
  23. De Pablo P, Chapple IL, Buckley CDet al. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009 ; 5 : 218–224. [CrossRef] [PubMed] [Google Scholar]
  24. Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol 2017 ; 13 : 606–620. [CrossRef] [PubMed] [Google Scholar]
  25. Maresz KJ, Hellvard A, Sroka Aet al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog 2013 ; 9 : e1003627. [CrossRef] [PubMed] [Google Scholar]
  26. Gully N, Bright R, Marino Vet al. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One 2014 ; 9 : e100838. [Google Scholar]
  27. Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016; 8 : 369ra176. [CrossRef] [PubMed] [Google Scholar]
  28. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009 ; 36 : 1004–1010. [CrossRef] [PubMed] [Google Scholar]
  29. Payne JB, Golub L. M Thiele GM, et al. The link between periodontitis and rheumatoid arthritis : A periodontist’s perspective. Curr Oral health Rep 2015 ; 2 : 20–29. [CrossRef] [PubMed] [Google Scholar]
  30. Golub LM PB, Reinhart RA, et al. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model. J Dental Res 2006 ; 85 : 102–105. [CrossRef] [PubMed] [Google Scholar]
  31. Mays JW, Sarmadi M, Moutsopoulos NM. Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases : Diagnosis and Clinical Management. J Evid Based Dent Pract 2012 ; 12 : 265–282. [CrossRef] [PubMed] [Google Scholar]
  32. Benli M, Batool F, Stutz C, et al. Orofacial manifestations and dental management of systemic lupus erythematosus : A review. Oral Dis 2021; 27 : 151–67. [CrossRef] [PubMed] [Google Scholar]
  33. Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome : A systemic autoimmune disease. Clin Exp Med 2022; 22 : 9–25. [CrossRef] [PubMed] [Google Scholar]
  34. Benz K, Baulig C, Knippschild S, et al. Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review. Int J Environ Res Public Health 2021; 18 : 5238. [CrossRef] [PubMed] [Google Scholar]
  35. Siar CH, Yeo KB, Nakano Ket al. Strawberry gingivitis as the first presenting sign of Wegener’s granulomatosis: report of a case. Eur J Med Res 2011 ; 16 : 331–334. [CrossRef] [PubMed] [Google Scholar]
  36. Zhu F, Ang JY. 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease. Curr Infect Dis Rep 2021; 23 : 3. [CrossRef] [PubMed] [Google Scholar]
  37. Bouaziz A., Le Scanff J., Chapelon-Abric C, et al. Oral involvement in sarcoidosis : Report of 12 cases. QJM 2012; 105 : 755–67. [CrossRef] [PubMed] [Google Scholar]
  38. Ramos-e-Silva M., Ferreira A, De-Moura-Castro JC.. Oral involvement in autoimmune bullous diseases. Clin Dermatol 2011 ; 29 : 443–454. [CrossRef] [PubMed] [Google Scholar]
  39. Sahin T, Brygo A, Delaporte Eet al. Les manifestations orales de la maladie de Crohn. Swiss Dent J 2017 ; 127 : 644–653. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.